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background:  We compared clinical outcomes after transradial intervention (TRI) and transfemoral intervention (TFI) in contemporary 
antiplatelet era.
methods:  Among 6,973 patients enrolled in a nationwide, prospective, multicenter registry from February to September 2013, eligible 
5,770 patients were classified into TRI (n = 4,938, 85.6%) and TFI (n = 832, 14.4%) groups. Bleeding and major adverse cardiac events 
(MACE; death, recurrent myocardial infarction, revascularization, or stent thrombosis) were compared. Propensity score (PS)-matched 
analysis was performed in 1,564 patients.
Results:  TRI group had significantly lower bleeding rate than TFI group in entire (1.1% vs. 2.9%, p < 0.001) and PS-matched (1.0% vs. 
2.8%, p = 0.012) cohorts. In multivariate regression, TRI was associated with bleeding in entire (odds ratio [OR] 0.50, 95% confidence 
interval [CI] 0.29-0.84, p = 0.009) and PS-matched (OR 0.36, 95% CI 0.16-0.84, p = 0.017) cohorts. Kaplan-Meier estimates showed that 
MACE-free survival was higher in TRI group than TFI group in entire (97.5% vs. 92.3%, log rank, p < 0.001) and PS-matched (96.7% vs. 
93.5%, log rank, p = 0.046) cohorts. In Cox proportional hazard model, TRI was an independent predictor of MACE in entire (hazard ratio 
[HR] 0.61, 95% CI 0.43-0.88, p = 0.009) and PS-matched (HR 0.55, 95% CI 0.33-0.93, p = 0.025) cohorts.
conclusion:  This study showed that TRI was associated with a lower bleeding rate and better clinical outcomes compared to TFI in 
contemporary real-world practice.
 
